Fenoprofen therapy in large-joint osteoarthritis: double-blind comparison with aspirin and longterm experience.

Author: BrookeJ W

Paper Details 
Original Abstract of the Article :
This study, designed to evaluate fenoprofen in patients with osteoarthritis, consisted of two phases: I. A double-blind crossover comparison of fenoprofen, 200 to 600 mg every six hours, to aspirin, 325 to 975 mg every six hours; II. Longterm use of fenoprofen in an open study design. During the fir...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/781234

データ提供:米国国立医学図書館(NLM)

Fenoprofen therapy in large-joint osteoarthritis: double-blind comparison with aspirin and long-term experience

The journey through the [arthritis] desert can be long and arduous, marked by pain, stiffness, and reduced mobility. This study explores the effectiveness of [fenoprofen] in treating osteoarthritis, a common condition that affects millions of people worldwide.

Double-Blind Comparison

The researchers conducted a [double-blind crossover comparison] of fenoprofen to aspirin, a well-established treatment for osteoarthritis. This method, like carefully navigating through a maze of sand dunes, allows for a fair comparison of the two treatments, minimizing the potential for bias. The study found that both fenoprofen and aspirin were significantly better than placebo in relieving pain and stiffness. Furthermore, fenoprofen demonstrated a slight advantage over aspirin in most of the studied variables.

Long-Term Experience

The researchers also conducted a [long-term open study] to evaluate the safety and efficacy of fenoprofen over extended periods. This long-term experience, like navigating through a vast desert over many days, provides valuable information about the drug's long-term effects. The study concluded that fenoprofen was safe for long-term use, exceeding two years, and did not precipitate or aggravate chronic disorders.

Dr. Camel's Conclusion

This study offers valuable insights into the use of fenoprofen in treating osteoarthritis. The researchers' meticulous approach, employing both double-blind and long-term open studies, provides a comprehensive understanding of the drug's effectiveness and safety. Fenoprofen emerges as a promising option for patients seeking relief from the pain and stiffness associated with osteoarthritis, offering a path toward improved mobility and quality of life. Just as a camel can traverse the desert for long distances, fenoprofen can help patients navigate the challenges of osteoarthritis, providing relief and allowing them to continue their journey.
Date :
  1. Date Completed 1976-09-25
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

781234

DOI: Digital Object Identifier

781234

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.